在线客服 
销售询价点击这里给我发消息

跟单及发票查询点击这里给我发消息

供应商联系点击这里给我发消息

总经理点击这里给我发消息

  Product Search
Input Product Name Or Cas No.
 Category
  Amino Acid Derivatives
  Heterocyclic Compounds
  API intermediates
  API
  Coupling Reagent
  Electronic Chemicals
  Carbohydrates
 Products
  5-​[3-​(6-​quinolinylm 
  4-​[3-​(6-​quinolinylm 
  3-​ethyl-​6-​(4,​ 
  4-​(7-​chloro-​3,̴ 
  4-​(7-​chloro-​3,̴ 
  5-​chloro-​3-​[[1-R 
  2,​5-​dimethyl-​4-R 
  1-​[(4-​methoxyphenyl)​ 
  B-​[3-​[[[2-​(1-​ 
  [trans-​4-​(aminocarbonyl)&# 
  1-​methyl-​beta-​oxoCy 
  4-​(1-​propyl-​3-̴ 
  2-​[[[(1,​1-​dimethyle 
  tetrahydro-​2-​(2-​met 
  3-​hydroxy-​alpha-​[(m 
  4-[5-(4-bromophenyl)-3-(trifluoromethyl) 
  bis(3-chlorophenyl)methanone 
  1-bromo-4-[(2-methylpropan-2-yl)oxy]benz 
  N-​butylCarbamic acid 1,​1-& 
  tert-butyl morpholine-4-carboxylate 
  alpha-​2-​propyn-​1-&# 
  2-​(trimethylsilyl)Benzothiazole 
  alpha-​(bromomethyl)​-​ 
  2-​phenyl-​1-​Pyrrolid 
  2-(2-hydroxyethylamino)-1-phenylethanol 
  2-​chloro-​1-​(2-̴ 
  2-​(diphenylmethyl)​Oxirane 
  beta-​(methylamino)Benzenepropanol 
  alpha-​[(methylamino)​methyl 
  3-​cyclohexylPyridine 
  1-​(2-​methyl-​1-̴ 
  4-​chloro-​alpha-​[(me 
  2-​methyl-​1-​Pyrrolid 
  4-​[(4-​methylphenyl)​ 
  2-​[4-​(methoxycarbonyl)R 
  alpha-​[(methylamino)​methyl 
  3-​amino-​alpha-​[(met 
  2-​(4-​methoxyphenyl)​ 
  alpha-​[(methylamino)​methyl 
  N-​ethyl-​N-​methylCar 
  3-​(2-​oxiranyl)Furan 
  4-​fluoro-​alpha-​[(me 
  1-​(3,​4-​dimethoxyphe 
  2-​(2-​oxiranyl)​Quino 
  2-​(cyclohexylmethyl)​tetrah 
  4-​cyclohexyl-​alpha,​ 
  3-​[2-​(2-​methoxyetho 
  2-​(4-​acetylphenyl)​- 
  2-​[2-​(3-​chloropheny 
  3-​(2-​phenylethyl)​-2 
  News

 
Successful complete of custom-synthesis project for BeiGene
2014-11-01

Congratulations on Rovathin successful complete of custom-synthesis project for BeiGene

About BeiGene (Beijing), Co.,Ltd

BeiGene is a clinical-stage biopharma company focused on discovering and developing innovative, best-in-class, targeted and immuno-oncology drugs that address severe unmet medical needs in a variety of cancer indications.The company collaboration with Merck Serono, the drug discovery unit of Merck KGaA, for BGB-290,currently is in Phase 1 development.
Copyright(C)2011,Suzhou Rovathin Foreign Trade Co.,Ltd. Supported by www.hxchem.net 后台管理 苏ICP备09008419号